Walden International Investment expands leadership team
The venture capital firm focuses its investments on biotechnology, software and internet with new additions to team.
Charles Hsu is the new general partner for Walden International Investment Group (WIIG), responsible for investments in the life sciences sector. Hsu began his venture capital career in 1990 with Advent International, where he was a partner. Eventually, Hsu moved to Walden VC where he was a partner immediately prior to this new appointment. At Walden VC, Hsu managed global investments in healthcare and the life sciences. WIIG's second appointment is Amos Barzilay, who will be the gen…
Please sign in or register
for free access to 1 article per month from AsianInvestor’s content and archives of over 16,000 articles.